[
    {
        "name": "Cardiology",
        "subtopics": [
            {
                "name": "Coronary artery disease",
                "questions": [
                    {
                        "question": "Which medications should be avoided in patients using nitrates?",
                        "choices": ["Sildenafil", "Aspirin", "Lisinopril", "Metoprolol"],
                        "correct_answer": "Sildenafil",
                        "explanation": "Sildenafil and other phosphodiesterase inhibitors [vardenafil, tadalafil] should be avoided in patients using nitrates because they can cause a dangerous drop in blood pressure due to their combined vasodilatory effects."
                    },                    
                    {
                        "question": "What is the proper use of nitrates in the management of angina to prevent tachyphylaxis?",
                        "choices": ["Use nitrates continuously without a break", "Establish a nitrate-free period of 8 to 12 hours per day", "Only use nitrates during physical activity", "Use nitrates only when other treatments fail"],
                        "correct_answer": "Establish a nitrate-free period of 8 to 12 hours per day",
                        "explanation": "To prevent nitrate tachyphylaxis, it is important to establish a nitrate-free period of 8 to 12 hours per day, typically overnight, during which nitrates are not used."
                    },
                    {
                        "question": "A patient with symptomatic coronary artery disease who is already on β-blockers and nitrates, BP at target, which other antianginal medication should be added?",
                        "choices": ["Ranolazine", "Furosemide", "Aspirin", "HCTZ"],
                        "correct_answer": "Ranolazine",
                        "explanation": "Ranolazine should be considered for patients with coronary artery disease who remain symptomatic despite optimal doses of β-blockers and nitrates"
                    },
                    {
                        "question": "When should ranolazine be avoided?",
                        "choices": ["In patients with uncontrolled hypertension", "In patients with a history of seizures", "In patients with liver cirrhosis", "In patients with QT prolongation"],
                        "correct_answer": "In patients with QT prolongation",
                        "explanation": "Ranolazine should be avoided in patients with bradycardia or prolonged QT interval, as it can exacerbate these conditions by further prolonging the QT interval and affecting heart rate."
                    },
                    {
                        "question": "Which of the following is NOT part of the four major classes of antianginal medications for stable angina?",
                        "choices": ["β-blockers", "Nitrates", "Calcium channel blockers", "Ranolazine", "ACE inhibitors"],
                        "correct_answer": "ACE inhibitors",
                        "explanation": "The four major classes of antianginal medications for stable angina are β-blockers, nitrates, calcium channel blockers, and ranolazine. ACE inhibitors  are not considered antianginal medications."
                    }                          
                ]
            },
            {
                "name": "Chest pain",
                "questions": [
                    {
                        "question": "A patient recently diagnosed with colon cancer, currently undergoing chemotherapy, presents to the ED with squeezing chest pain. Which medication may have contributed to this?",
                        "choices": ["Leucovorin", "5-Fluorouracil", "Oxaliplatin", "Zofran"],
                        "correct_answer": "5-Fluorouracil",
                        "explanation": "FOLFOX is a common chemotherapy regimen for colorectal cancer that includes leucovorin (folinic acid), 5-Fluorouracil (5-FU), and oxaliplatin. One of its components, 5-FU, can cause coronary vasospasms leading to myocardial ischemia. Patients may present with ECG changes such as ST-segment elevation and elevated troponin levels, indicating myocardial injury, even when angiography shows no occlusive coronary artery disease."
                    },
                    {
                        "question": "A young patient presents to the emergency department with chest pain and ST elevation on the initial ECG. After administration of aspirin and nitroglycerin, he is sent for cardiac catheterization. The patient exhibits anxiety, diaphoresis, tachycardia, and hypertension, and admits to recent cocaine use. What is the next best step?",
                        "choices": ["Thrombolytics", "Lorazepam IV", "Zofran", "Lisinopril"],
                        "correct_answer": "Lorazepam IV",
                        "explanation": "Lorazepam or other benzodiazepines are the treatment of choice for managing cocaine-induced chest pain and associated symptoms. They reduce anxiety, sympathetic hyperactivity, and the risk of arrhythmias or hypertension. Avoid beta-blockers as they can exacerbate coronary vasospasm."
                    }                    
                    
                ]
            },
            {
                "name": "Atrial fibrillation/flutter",
                "questions": [
                    {
                        "question": "Which arrhythmia is characterized by an irregularly irregular rhythm?",
                        "choices": ["Atrial Flutter", "Atrial Fibrillation", "Ventricular Tachycardia", "Sinus Arrhythmia"],
                        "correct_answer": "Atrial Fibrillation",
                        "explanation": "Atrial fibrillation is characterized by an irregularly irregular heart rhythm with no P waves."
                    },
                    {
                        "question": "Which of the following agents is NOT used for RATE CONTROL in a patient with atrial fibrillation?",
                        "choices": ["β-blockers", "Calcium channel blockers", "Digoxin", "Diuretics"],
                        "correct_answer": "Diuretics",
                        "explanation": "Rate control in atrial fibrillation is achieved by blocking the AV node, which can be done with β-blockers, calcium channel blockers, and digoxin. This slows the heart rate but does not convert the patient to sinus rhythm, which is typically achieved by rhythm control strategies."
                    },
                    {
                        "question": "How does digoxin achieve AV node blockage?",
                        "choices": ["Increases sympathetic tone", "Enhances vagal activity", "Blocks calcium channels", "Inhibits beta-receptors"],
                        "correct_answer": "Enhances vagal activity",
                        "explanation": "Digoxin slows AV node conduction by increasing parasympathetic (vagal) tone, reducing the heart rate."
                    },
                    {
                        "question": "A patient undergoing a routine ECG for unrelated reasons is found to have atrial fibrillation with rapid ventricular response (HR > 100 bpm). What complication may arise if the heart rate is not controlled?",
                        "choices": ["Mitral stenosis", "Ventricular septal defect", "Tachyarrhythmia-induced cardiomyopathy", "Pulmonary embolism"],
                        "correct_answer": "Tachyarrhythmia-induced cardiomyopathy",
                        "explanation": "Persistent rapid ventricular response in atrial fibrillation can lead to tachyarrhythmia-induced cardiomyopathy, characterized by left ventricular dysfunction due to sustained high heart rates. Although pulmonary emboism can happen with atrial fibrillation, it's very rare"
                    },
                    {
                        "question": "In a patient with atrial fibrillation and no significant valvular abnormality, how do you assess the need for anticoagulation?",
                        "choices": ["All patients need anticoagulation", "CHA2DS2-VASc score", "HEART score", "HAS-BLED score"],
                        "correct_answer": "CHA2DS2-VASc score",
                        "explanation": "The CHA2DS2-VASc score is used to assess stroke risk and guide the need for anticoagulation in patients with non-valvular atrial fibrillation."
                    },
                    {
                        "question": "A patient with atrial fibrillation comes to the ER complaining of lightheadedness. HR is 167 bpm and BP is 70/56 mmHg. What is your next step?",
                        "choices": ["Give Cardizem IV", "Cardioversion", "Defibrillation", "Give Metoprolol IV"],
                        "correct_answer": "Cardioversion",
                        "explanation": "In a patient with atrial fibrillation and signs of hemodynamic instability (e.g., hypotension, lightheadedness), immediate cardioversion is indicated to restore sinus rhythm and stabilize the patient."
                    },
                    {
                        "question": "A patient with newly diagnosed atrial fibrillation is found to have severe mitral stenosis on the echocardiogram. You decide to start the patient on anticoagulation. Which agent would you use?",
                        "choices": ["Rivaroxaban", "Warfarin", "Apixaban", "Dabigatran", "Edoxaban"],
                        "correct_answer": "Warfarin",
                        "explanation": "For patients with atrial fibrillation and severe mitral stenosis or a mechanical valve, warfarin is the only recommended anticoagulant due to its proven efficacy in these populations. Direct oral anticoagulants (DOACs) are not recommended due to the increased risk of thromboembolism."
                      }
                      
                ]
            }
        ]
    },
    {
        "name": "Rheumatology",
        "subtopics": [
            {
                "name": "Eosinophilic granulomatosis with polyangiitis",
                "questions": [
                    {
                        "question": "The prodromal phase of eosinophilic granulomatosis with polyangiitis [EGPA] is characterized by which of the following?",
                        "choices": ["Asthma and eosinophilia", "Hemoptysis and weight loss", "Rash and fever", "Joint pain and fatigue"],
                        "correct_answer": "Asthma and eosinophilia",
                        "explanation": "The prodromal phase of eosinophilic granulomatosis with polyangiitis [EGPA] is typically characterized by asthma and eosinophilia. This phase may precede the more severe vasculitic features of the disease."
                    },
                    {
                        "question": "Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by all of the following phases except for which?",
                        "choices": ["Prodromal phase", "Eosinophilic phase", "Vasculitic phase", "Lung phase"],
                        "correct_answer": "Lung phase",
                        "explanation": "Lung phase is not a recognized phase of EGPA, though pulmonary involvement occurs during other phases. EGPA phases occur as follows: 1. Prodromal phase characterized by asthma and eosinophilia. 2. Eosinophilic phase marked by tissue eosinophilia and systemic symptoms like fever and weight loss. 3. Vasculitic phase involves small-vessel vasculitis. "
                    },
                    {
                        "question": "Which of the following serologic markers is associated with eosinophilic granulomatosis with polyangiitis (EGPA)?",
                        "choices": ["p-ANCA [anti-MPO]", "c-ANCA [anti-PR3]", "ANA", "Anti-dsDNA"],
                        "correct_answer": "p-ANCA [anti-MPO]",
                        "explanation": "p-ANCA [anti-MPO] is associated with EGPA, although only about half of patients are positive for this marker."
                    }                   
                ]
            },
            {
                "name": "Systemic lupus erythematosus",
                "questions": [
                    {
                        "question": "In the diagnosis of lupus, what is the significance of an ANA test?",
                        "choices": ["ANA is positive in most lupus patients", "ANA is a specific marker for lupus", "ANA negative confirms lupus", "ANA is always negative in lupus"],
                        "correct_answer": "ANA is positive in most lupus patients",
                        "explanation": "In lupus, more than 95% of patients are ANA positive. If ANA is negative, it is unlikely to be lupus, as ANA is a sensitive but not specific marker for the disease."
                    }                    
                ]
            }
        ]
    },
    {
        "name": "Gastroenterology",
        "subtopics": [
            {
                "name": "Hemochromatosis",
                "questions": [
                    {
                        "question": "Why does iron deposition in tissues cause damage in hemochromatosis?",
                        "choices": ["Iron directly causes DNA mutations", "Iron overload leads to oxidative stress", "Iron interferes with calcium metabolism", "Iron accumulates in blood vessels, causing blockages"],
                        "correct_answer": "Iron overload leads to oxidative stress",
                        "explanation": "In hemochromatosis, excess iron accumulates in tissues and catalyzes the formation of free radicals, leading to oxidative stress, which damages cells, tissues, and organs."
                    }                    
                ]
            },
            {
                "name": "Liver cirrhosis",
                "questions": [
                    {
                        "question": "Which of the following is the least common cause of cirrhosis?",
                        "choices": [
                          "Alcohol",
                          "Metabolic dysfunction-associated steatotic liver disease",
                          "Chronic viral hepatitis",
                          "Alpha-1 antitrypsin deficiency"
                        ],
                        "correct_answer": "Alpha-1 antitrypsin deficiency",
                        "explanation": "Alpha-1 antitrypsin deficiency is a rare genetic disorder that can lead to cirrhosis, while alcohol, metabolic dysfunction-associated steatotic liver disease (formerly NAFLD), and chronic viral hepatitis are much more common causes."
                    },
                    {
                        "question": "In decompensated liver cirrhosis, you can find all of the following abnormalities except for?",
                        "choices": [
                          "Hypoalbuminemia",
                          "Hyperammonemia",
                          "Elevated INR",
                          "High BUN",
                          "Thrombocytopenia"
                        ],
                        "correct_answer": "High BUN",
                        "explanation": "Decompensated liver cirrhosis typically presents with hypoalbuminemia, hyperammonemia, elevated INR, and thrombocytopenia due to decreased liver synthetic function and portal hypertension. High BUN is not common because the liver's impaired ability to synthesize urea usually results in lower BUN levels."
                    },
                    {
                        "question": "A patient with liver cirrhosis and ascites was placed on furosemide and spironolactone and subsequently developed painful gynecomastia. What is your next step?",
                        "choices": [
                          "Stop spironolactone and increase the dose of furosemide",
                          "Switch spironolactone to eplerenone",
                          "Stop both diuretics",
                          "Switch furosemide to hydrochlorothiazide"
                        ],
                        "correct_answer": "Switch spironolactone to eplerenone",
                        "explanation": "Spironolactone can cause gynecomastia due to its anti-androgen effects. Eplerenone is a selective aldosterone antagonist with less anti-androgen activity, making it a better alternative in patients who develop this side effect."
                    },
                    {
                        "question": "Which is the correct treatment for ascites?",
                        "choices": [
                          "Furosemide alone",
                          "Spironolactone with furosemide",
                          "Propranolol",
                          "Indapamide"
                        ],
                        "correct_answer": "Spironolactone with furosemide",
                        "explanation": "The standard treatment for ascites in liver cirrhosis is a combination of spironolactone and furosemide. Spironolactone, an aldosterone antagonist, helps reduce sodium retention and fluid accumulation."
                    },
                    {
                        "question": "Which of the following medications should be avoided in liver cirrhosis complicated by ascites?",
                        "choices": [
                          "NSAIDs",
                          "Amlodipine",
                          "Hydralazine",
                          "Hydrocodone"
                        ],
                        "correct_answer": "NSAIDs",
                        "explanation": "NSAIDs should be avoided in patients with liver cirrhosis and ascites because they inhibit prostaglandin synthesis, leading to reduced renal blood flow. This can worsen renal function and increase the risk of hepatorenal syndrome."
                    },
                    {
                        "question": "A patient with a history of liver cirrhosis presents with hematemesis. He is tachycardic but otherwise vitally stable. He has been started on pantoprazole and GI has been consulted for endoscopy. What is the next step in management?",
                        "choices": [
                          "Start octreotide only",
                          "Start ceftriaxone only",
                          "Start octreotide and ceftriaxone",
                          "Start famotidine",
                          "Start norepinephrine"
                        ],
                        "correct_answer": "Start octreotide and ceftriaxone",
                        "explanation": "In cirrhotic patients with suspected variceal bleeding, management includes the use of octreotide to reduce portal pressure via splanchnic vasoconstriction, and prophylactic antibiotics (such as ceftriaxone) to prevent bacterial infections, which are common and can worsen outcomes in variceal hemorrhage."
                    },
                    {
                        "question": "A patient with esophageal varices presents with hematemesis. He is at risk for developing all of the following complications EXCEPT for:",
                        "choices": [
                          "Hepatic encephalopathy",
                          "Hemorrhagic shock",
                          "Aspiration pneumonitis",
                          "Infection",
                          "Heart failure"
                        ],
                        "correct_answer": "Heart failure",
                        "explanation": "Variceal bleeding in cirrhotic patients can lead to complications such as hepatic encephalopathy (due to increased nitrogen load), hemorrhagic shock (from blood loss), aspiration pneumonitis (due to vomiting and encephalopathy), and infection (from bacterial translocation). Heart failure is not a typical complication associated with variceal bleeding."
                    },
                    {
                        "question": "A patient with refractory ascites, despite being on maximal therapy with furosemide and spironolactone, requires therapeutic paracentesis almost every week. What is the next step in management?",
                        "choices": [
                          "Transjugular Intrahepatic Portosystemic Shunt (TIPS)",
                          "Continue with paracentesis",
                          "Place a catheter in the abdomen",
                          "Add amiloride to the current regimen",
                          "Start nadolol"
                        ],
                        "correct_answer": "Transjugular Intrahepatic Portosystemic Shunt (TIPS)",
                        "explanation": "In patients with refractory ascites who require frequent paracentesis despite maximal diuretic therapy, a Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure is indicated to reduce portal hypertension and decrease the formation of ascites."
                    },
                    {
                        "question": "A cirrhotic patient underwent a Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure for refractory ascites and recurrent esophageal variceal bleeding. You inform the patient he is at increased risk for which of the following?",
                        "choices": [
                          "Hepatic encephalopathy",
                          "Acute renal failure",
                          "Pulmonary embolism",
                          "Portal vein thrombosis"
                        ],
                        "correct_answer": "Hepatic encephalopathy",
                        "explanation": "TIPS creates a shunt that bypasses the liver, reducing its ability to detoxify neurotoxins such as ammonia. This predisposes patients to hepatic encephalopathy, a common complication following the procedure."
                    },
                    {
                        "question": "A patient with liver cirrhosis comes to the ED complaining of weakness. His creatinine is 2.3 mg/dL (baseline 0.9 mg/dL) and he is currently on diuretics for ascites. What is the next step in management?",
                        "choices": [
                          "Stop diuretics and trial albumin and volume expansion",
                          "Start midodrine",
                          "Perform paracentesis",
                          "This is hepatorenal syndrome"
                        ],
                        "correct_answer": "Stop diuretics and trial albumin and volume expansion",
                        "explanation": "In patients with cirrhosis, worsening renal function (as evidenced by an increase in creatinine) may indicate hepatorenal syndrome but volume depletion is more common. Diuretics can exacerbate renal hypoperfusion in this setting. Therefore, the appropriate management is to stop diuretics and initiate a trial of albumin and volume expansion, then repeat labs to assess for improvement."
                    },
                    {
                        "question": "Which of the following agents is preferred for prophylaxis in patients with liver cirrhosis who have a history of spontaneous bacterial peritonitis?",
                        "choices": [
                          "Aminoglycosides",
                          "Fluoroquinolones",
                          "Clindamycin",
                          "No need for prophylaxis"
                        ],
                        "correct_answer": "Fluoroquinolones",
                        "explanation": "Fluoroquinolones (such as norfloxacin or ciprofloxacin) are preferred for prophylaxis in cirrhotic patients with a history of spontaneous bacterial peritonitis, as they effectively reduce the risk of recurrence."
                    }
                      
                      
                      
                      
                      
                      
                      
                      
                      
                      
                      
                    
                ]
            },
            {
                "name": "Acute pancreatitis",
                "questions": [
                    {
                        "question": "What is the most common cause of acute pancreatitis?",
                        "choices": ["Hypertriglyceridemia", "Alcohol consumption", "Drug-induced", "Scorpion sting"],
                        "correct_answer": "Alcohol consumption",
                        "explanation": "Alcohol consumption along with gallstones is the most common cause of acute pancreatitis."
                    },
                    {
                        "question": "Which of the following causes of acute pancreatitis is associated with hyponatremia?",
                        "choices": ["Hypercalcemia", "Hypertriglyceridemia", "Gallstones", "Endoscopic retrograde cholangiopancreatography"],
                        "correct_answer": "Hypertriglyceridemia",
                        "explanation": "Hypertriglyceridemia causes pseudohyponatremia by interfering with laboratory measurements in certain assays, leading to falsely low sodium levels due to plasma water displacement by excess lipids."
                    },
                    {
                        "question": "Which of the following is NOT a criterion for the diagnosis of acute pancreatitis?",
                        "choices": ["Epigastric abdominal pain", "Elevated lipase level 3x upper limit of normal", "Imaging findings of acute pancreatitis", "Fever"],
                        "correct_answer": "Fever",
                        "explanation": "Acute pancreatitis is diagnosed if the patient meets 2 out of 3 criteria: (a) epigastric abdominal pain, (b) lipase elevated 3x upper limit of normal, (c) imaging showing acute pancreatitis."
                    }                    
                ]
            }
        ]
    },
    {
        "name": "Pulmonology",
        "subtopics": [
            {
                "name": "Chronic obstructive pulmonary dsisease",
                "questions": [
                    {
                        "question": "Alpha-1 antitrypsin [AAT] deficiency usually involves which lobes of the lung?",
                        "choices": ["Upper lobes", "Lower lobes", "Doesn't affect the lung at all"],
                        "correct_answer": "Lower lobes",
                        "explanation": "Alpha-1 antitrypsin deficiency primarily affects the lower lobes of the lung due to the accumulation of neutrophil elastase activity, which damages the alveoli."
                    }
                    
                ]
            }
        ]
    },
    {
        "name": "Nephrology",
        "subtopics": [
            {
                "name": "Electrolyte abnormalities",
                "questions": [
                    {
                        "question": "A patient presents to the hospital with severe hypokalemia. Which of the following fluids should be avoided in this patient?",
                        "choices": [
                          "Lactated Ringer's solution",
                          "Normal Saline",
                          "Dextrose 5% Water",
                          "Albumin Infusion"
                        ],
                        "correct_answer": "Dextrose 5% Water",
                        "explanation": "Dextrose 5% Water should be avoided in patients with severe hypokalemia because the dextrose stimulates insulin secretion, which drives potassium into cells, further lowering serum potassium levels."
                    },
                    {
                        "question": "Which of the following abnormalities can be seen in patients taking omeprazole?",
                        "choices": [
                          "Hyponatremia",
                          "Hypoammonemia",
                          "Hypomagnesemia",
                          "Metabolic acidosis",
                          "Respiratory acidosis"
                        ],
                        "correct_answer": "Hypomagnesemia",
                        "explanation": "Omeprazole, a proton pump inhibitor, has been associated with hypomagnesemia due to decreased intestinal magnesium absorption."
                    },
                    {
                        "question": "A patient comes in with respiratory distress due to a COPD exacerbation. EMS has provided multiple breathing treatments for the patient. Which of the following abnormalities is most likely to be found on the patient's labs?",
                        "choices": [
                          "Increase in creatinine",
                          "Increase in pH",
                          "Hypokalemia",
                          "Metabolic acidosis"
                        ],
                        "correct_answer": "Hypokalemia",
                        "explanation": "Multiple beta-agonist treatments, such as albuterol, stimulate the Na/K-ATPase and cause potassium to shift into cells, resulting in hypokalemia. Remember albuterol can be used in the treatment of hyperkalemia."
                    },
                    {
                        "question": "Digoxin toxicity will cause which of the following electrolyte disturbances?",
                        "choices": [
                          "Hyperkalemia",
                          "Hypernatremia",
                          "Hypercalcemia",
                          "Hyperglycemia"
                        ],
                        "correct_answer": "Hyperkalemia",
                        "explanation": "Digoxin toxicity inhibits the Na+/K+ ATPase pump, leading to an increase in extracellular potassium levels and resulting in hyperkalemia."
                    },
                    {
                        "question": "Hypokalemia can cause all of the following conditions except for?",
                        "choices": [
                          "Rhabdomyolysis",
                          "Cardiac arrhythmia",
                          "Ileus",
                          "Respiratory muscle weakness",
                          "Seizures"
                        ],
                        "correct_answer": "Seizures",
                        "explanation": "Potassium is essential for the proper generation and conduction of action potentials in smooth, striated, and cardiac muscles. Hypokalemia can lead to conditions such as rhabdomyolysis, cardiac arrhythmias, ileus, and respiratory muscle weakness. However, seizures are not typically a direct consequence of hypokalemia."
                    }
                      
                      
                      
                      
                      
                    
                ]
            }
        ]
    },
    {
        "name": "Endocrinology",
        "subtopics": [
            {
                "name": "Diabetes mellitus",
                "questions": [
                    {
                        "question": "Which of the following diabetes medications causes vitamin B12 deficiency?",
                        "choices": ["Glipizide", "Metformin", "Empagliflozin", "Insulin glargine", "Semaglutide"],
                        "correct_answer": "Metformin",
                        "explanation": "Metformin is associated with vitamin B12 deficiency, particularly in long-term use. This is thought to be due to its effect on the small intestine, potentially impairing vitamin B12 absorption."
                    },
                    {
                        "question": "What is the hemoglobin A1c range for prediabetes?",
                        "choices": ["4.5%-5.6%", "5.7%-6.4%", "6.5%-7.0%", "7.1%-8.0%"],
                        "correct_answer": "5.7%-6.4%",
                        "explanation": "A hemoglobin A1c range of 5.7%-6.4% is indicative of prediabetes. A value of 6.5% or higher is diagnostic for diabetes."
                    },
                    {
                        "question": "In which of the following conditions will hemoglobin A1c be falsely low?",
                        "choices": ["Hemolytic anemia", "Hyperthyroidism", "Obesity", "Vitamin D deficiency"],
                        "correct_answer": "Hemolytic anemia",
                        "explanation": "Hemoglobin A1c can be falsely low in patients with hemolytic anemia because the shortened lifespan of red blood cells reduces the time available for glucose to attach to hemoglobin."
                    },
                    {
                        "question": "Which of the following antidiabetic medications is recommended for patients with heart failure?",
                        "choices": ["Metformin", "Sulfonylureas", "SGLT2 inhibitors", "DPP-4 inhibitors"],
                        "correct_answer": "SGLT2 inhibitors",
                        "explanation": "SGLT2 inhibitors are recommended for patients with heart failure as they have shown to reduce hospitalization rates and improve outcomes in heart failure patients, in addition to their effects on blood glucose control."
                    },
                    {
                        "question": "Which of the following medications should be considered in diabetic patients with established atherosclerotic cardiovascular disease (ASCVD) or at increased risk for ASCVD?",
                        "choices": ["Metformin", "GLP-1 receptor agonist", "Insulin", "Sulfonylureas"],
                        "correct_answer": "GLP-1 receptor agonist",
                        "explanation": "GLP-1 receptor agonists and SGLT2 inhibitors have been shown to reduce cardiovascular events in patients with established ASCVD or those at high risk, making them preferred treatment options in these populations."
                    },
                    {
                        "question": "When should screening for complications in patients with type 1 diabetes begin?",
                        "choices": ["Immediately after diagnosis", "1 year after diagnosis", "5 years after diagnosis", "10 years after diagnosis"],
                        "correct_answer": "5 years after diagnosis",
                        "explanation": "Screening for complications such as retinopathy, nephropathy, and neuropathy should begin 5 years after the diagnosis of type 1 diabetes, as these complications typically develop later in the course of the disease. Screening should start immediately after diagnosis in type 2 DM."
                    },
                    {
                        "question": "A patient presents to your office with polyuria, polydipsia, and fatigue. You check a serum glucose level and it’s 221 mg/dL. What do you tell the patient?",
                        "choices": ["You have diabetes mellitus for sure", "You need further testing", "Come back tomorrow to get tested again", "You don’t have diabetes mellitus"],
                        "correct_answer": "You have diabetes mellitus for sure",
                        "explanation": "Hyperglycemic symptoms such as polyuria, polydipsia, and fatigue with a random plasma glucose level ≥200 mg/dL with is diagnostic of diabetes mellitus"
                    },
                    {
                        "question": "A patient with type 1 diabetes mellitus presents with fatigue, nausea, and vomiting for the past 3 weeks. He has borderline low blood pressure, and his insulin requirements have decreased. Which of the following could be a possible explanation for his presentation?",
                        "choices": ["Adrenal failure", "Hyperthyroidism", "Myocardial infarction", "Pneumonia"],
                        "correct_answer": "Adrenal failure",
                        "explanation": "Patients with type 1 diabetes mellitus (autoimmune) are at increased risk of developing other autoimmune conditions, such as adrenal insufficiency. This can present with fatigue, nausea, vomiting, hypotension, and reduced insulin requirements."
                    },
                    {
                        "question": "Which of the following medications is NOT used for the treatment of diabetic nephropathy?",
                        "choices": ["Lisinopril", "Losartan", "Empagliflozin", "Finerenone", "Hydrochlorothiazide"],
                        "correct_answer": "Hydrochlorothiazide",
                        "explanation": "Hydrochlorothiazide is not used for the treatment of diabetic nephropathy and can potentially cause hyperglycemia. Lisinopril (ACE inhibitor), Losartan (ARB), Empagliflozin (SGLT2 inhibitor), and Finerenone (nonsteroidal mineralocorticoid receptor antagonist) are all used to manage diabetic nephropathy by reducing albuminuria and slowing disease progression."
                    },
                    {
                        "question": "Which of the following medications increases the risk for developing diabetes mellitus?",
                        "choices": ["Ondansetron", "Aspirin", "Amlodipine", "Atorvastatin"],
                        "correct_answer": "Atorvastatin",
                        "explanation": "Atorvastatin and other statins are associated with an increased risk of developing diabetes mellitus, particularly in patients with preexisting risk factors. Ondansetron (antiemetic), Aspirin (antiplatelet), and Amlodipine (calcium channel blocker) are not associated with an increased risk of diabetes."
                    },
                    {
                        "question": "A patient with long-standing diabetes mellitus presents with early satiety, nausea, and vomiting. She reports experiencing similar symptoms in the past and is currently taking gabapentin for diabetic neuropathy. What is the appropriate treatment for her current condition?",
                        "choices": ["Lansoprazole", "Metoclopramide", "Propranolol", "Aspirin"],
                        "correct_answer": "Metoclopramide",
                        "explanation": "Metoclopramide is the first-line agent for diabetic gastroparesis. It works by blocking dopamine receptors and stimulating motility in the upper gastrointestinal tract, which promotes gastric emptying and reduces nausea."
                    },
                    {
                        "question": "Patients on sodium-glucose cotransporter-2 (SGLT-2) inhibitors are at increased risk for which of the following conditions?",
                        "choices": ["Diabetic ketoacidosis", "Hyperosmolar hyperglycemic state ", "Heart failure exacerbation", "Diabetic gastroparesis"],
                        "correct_answer": "Diabetic ketoacidosis",
                        "explanation": "SGLT-2 inhibitors increase the risk of euglycemic diabetic ketoacidosis (DKA) by promoting urinary glucose excretion, which can lower plasma glucose levels and possibly decrease insulin secretion promoting ketogenesis. This can lead to an accumulation of ketones despite relatively normal glucose levels, resulting in euglycemic DKA."
                    }
                      
                      
                ]
            },
            {
                "name": "Adrenal gland disorders",
                "questions": [
                    {
                        "question": "Addison disease results in loss of which of the following hormones?",
                        "choices": ["Cortisol only", "Cortisol and aldosterone only", "Aldosterone only", "Cortisol, aldosterone, and adrenal androgen", "Cortisol and adrenal androgen only"],
                        "correct_answer": "Cortisol, aldosterone, and adrenal androgen",
                        "explanation": "Addison disease is another name for primary adrenal insufficiency, which affects all three layers of the adrenal cortex. This results in deficiencies of cortisol, aldosterone, and adrenal androgens."
                    },
                    {
                        "question": "The most common cause of primary adrenal insufficiency is which etiology?",
                        "choices": ["Autoimmune", "Ischemic", "Traumatic", "Senile"],
                        "correct_answer": "Autoimmune",
                        "explanation": "The most common cause of primary adrenal insufficiency is autoimmune,."
                    },
                    {
                        "question": "You are seeing a patient in the emergency with hypotension. You are suspecting adrenal insufficiency. After giving IV fluids, which of the following agents should be administered next?",
                        "choices": ["Hydrocortisone", "Dexamethasone", "Prednisone", "Methylprednisolone", "IV fluids is enough"],
                        "correct_answer": "Dexamethasone",
                        "explanation": "In suspected adrenal insufficiency, dexamethasone is preferred in the acute setting, as it will not interfere with serum AM cortisol testing. While hydrocortisone is the preferred treatment for adrenal failure, it can affect cortisol testing."
                    },
                    {
                        "question": "Which of the following laboratory findings is not usually caused by adrenal failure?",
                        "choices": ["Hyponatremia", "Hypoglycemia", "Hyperammonemia", "Hyperkalemia", "Eosinophilia"],
                        "correct_answer": "Hyperammonemia",
                        "explanation": "Hyperammonemia is not usually seen in adrenal failure. However, hyponatremia, hypoglycemia, hyperkalemia, and eosinophilia are common findings in adrenal insufficiency due to hormonal imbalances."
                    },
                    {
                        "question": "Hyperpigmentation is seen in?",
                        "choices": ["Primary adrenal insufficiency", "Secondary adrenal insufficiency", "Seen equally in both disorders"],
                        "correct_answer": "Primary adrenal insufficiency",
                        "explanation": "Hyperpigmentation is seen in primary adrenal insufficiency due to increased production of proopiomelanocortin (POMC), which is converted into corticotropin (ACTH) and melanocyte-stimulating hormone (MSH). MSH stimulates melanocytes, leading to hyperpigmentation."
                    }
                      
                           
                ]
            },
            {
                "name": "Hypercalcemia",
                "questions": [
                    {
                        "question": "What is the mechanism of lithium-induced hypercalcemia?",
                        "choices": ["Increase in PTH level", "Increase in 1,25(OH)₂ vitamin D level", "Direct effect on bone resorption", "Stimulates release of calcium from striated muscle"],
                        "correct_answer": "Increase in PTH level",
                        "explanation": "Lithium-induced hypercalcemia occurs due to increased secretion of parathyroid hormone (PTH). Lithium raises the set point at which calcium suppresses PTH release, leading to elevated PTH levels and subsequent hypercalcemia."
                    },
                    {
                        "question": "Which antihypertensive is preferred in patients with hypercalciuria and recurrent calcium nephrolithiasis?",
                        "choices": ["Lisinopril", "Indapamide", "Metoprolol", "Hydralazine"],
                        "correct_answer": "Indapamide",
                        "explanation": "Thiazide diuretics, such as indapamide, reduce urinary calcium excretion by increasing calcium reabsorption in the distal tubule, making them the preferred choice for patients with hypercalciuria and recurrent calcium nephrolithiasis."
                    }, 
                    {
                        "question": "Hypercalcemia, metabolic alkalosis, and renal insufficiency are seen in?",
                        "choices": ["Overdose with calcium carbonate", "Overdose with famotidine", "Alcohol intoxication", "Removal of parathyroid glands"],
                        "correct_answer": "Overdose with calcium carbonate",
                        "explanation": "Excessive intake of calcium carbonate can lead to milk-alkali syndrome, characterized by hypercalcemia, metabolic alkalosis, and renal insufficiency."
                    },
                    {
                        "question": "Tertiary hyperparathyroidism occurs due to?",
                        "choices": ["Chronic hypocalcemia", "Adenoma of the parathyroid glands", "Hypothalamus producing PTH", "Increase in vitamin D synthesis"],
                        "correct_answer": "Chronic hypocalcemia",
                        "explanation": "Long-standing hypocalcemia leads to a persistent increase in parathyroid hormone (PTH) secretion, initially causing secondary hyperparathyroidism. Over time, continuous stimulation results in parathyroid gland hyperplasia and autonomous PTH production, leading to tertiary hyperparathyroidism."
                    },
                    {
                        "question": "What is the primary defect in familial hypocalciuric hypercalcemia (FHH)?",
                        "choices": [
                          "Gain-of-function mutation in the calcium-sensing receptor",
                          "Loss-of-function mutation in the calcium-sensing receptor",
                          "Increased renal calcium excretion",
                          "Excess parathyroid hormone (PTH) secretion due to parathyroid adenoma"
                        ],
                        "correct_answer": "Loss-of-function mutation in the calcium-sensing receptor",
                        "explanation": "Familial hypocalciuric hypercalcemia (FHH) is caused by a loss-of-function mutation in the calcium-sensing receptor on parathyroid cells and in the kidneys. This results in higher than normal serum calcium concentrations being required to suppress PTH release, leading to mild hypercalcemia, hypocalciuria, and normal to slightly elevated PTH levels."
                      }
                      
                      
                           
                ]
            }
        ]
    },
    {
        "name": "Neurology",
        "subtopics": [
            {
                "name": "Stroke",
                "questions": [
                    {
                        "question": "What is the next step in a patient who presents with right-sided weakness that started 30 minutes ago?",
                        "choices": ["CT head without contrast", "Chest x-ray", "Complete blood count", "CT angiogram of the chest"],
                        "correct_answer": "CT head without contrast",
                        "explanation": "The first step in stroke evaluation is a head CT scan without contrast, which is crucial for distinguishing ischemic from hemorrhagic stroke. This imaging rules out intracranial hemorrhage, a necessary step before considering thrombolytic therapy."
                    },
                    {
                        "question": "What is the next step in a patient who presents with right-sided weakness that started 30 minutes ago?",
                        "choices": ["MRI of the brain", "CT head with contrast", "Basic metabolic panel", "Fingerstick glucose"],
                        "correct_answer": "Fingerstick glucose",
                        "explanation": "A fingerstick glucose check should be performed to promptly rule out hypoglycemia, a stroke mimic, as the cause of neurological abnormalities. Since hypoglycemia is a readily reversible condition, early identification is crucial."
                    },
                    {
                        "question": "In a patient suspected of having a stroke, which imaging modality is the most sensitive for detection?",
                        "choices": ["CT head without contrast", "CT angiogram of head and neck", "MRI of the brain without contrast", "D-dimer"],
                        "correct_answer": "MRI of the brain without contrast",
                        "explanation": "MRI is the most sensitive imaging modality for detecting acute ischemic strokes because it can reveal cytotoxic edema, a critical sign of early infarction, within minutes of stroke onset."
                    },
                    {
                        "question": "In a patient presenting with right-sided weakness, dysphagia, and aphasia, with an unknown time of last known well and not amenable to endovascular therapy, what is the next best step in management?",
                        "choices": ["Oral aspirin", "Normalize blood pressure", "Acetaminophen", "Rectal aspirin"],
                        "correct_answer": "Rectal aspirin",
                        "explanation": "Aspirin is recommended within 24 to 48 hours of symptom onset in patients with acute ischemic stroke. In cases where dysphagia poses a risk for aspiration, rectal aspirin should be administered."
                    }                                          
                ]
            },
            {
                "name": "Parkinson Disease",
                "questions": [
                    {
                        "question": "Which of the following signs or symptoms is required for the diagnosis of Parkinson's disease?",
                        "choices": ["Muscle rigidity", "Bradykinesia", "Resting tremor", "Hallucinations"],
                        "correct_answer": "Bradykinesia",
                        "explanation": "For the diagnosis of Parkinson’s disease, the patient must exhibit bradykinesia, which is essential. In addition, at least one of the following must also be present: rigidity and/or resting tremor."
                    }             
                ]
            }
        ]
    },
    {
        "name": "Infectious Disease",
        "subtopics": [
            {
                "name": "Antibiotics",
                "questions": [
                    {
                        "question": "Which of the following antibiotics does NOT cover methicillin-resistant Staphylococcus aureus [MRSA]?",
                        "choices": ["Linezolid", "Vancomycin", "Ceftriaxone", "Daptomycin"],
                        "correct_answer": "Ceftriaxone",
                        "explanation": "Linezolid, vancomycin, and daptomycin cover MRSA. Ceftriaxone does not."
                    },
                    {
                        "question": "A patient with an MRSA infection who was started on an oral antibiotic approximately 10 days ago is found to have low platelets on a routine blood check. Which antibiotic was most likely used?",
                        "choices": [
                          "Cefdinir",
                          "Linezolid",
                          "Vancomycin",
                          "Metronidazole"
                        ],
                        "correct_answer": "Linezolid",
                        "explanation": "Linezolid can cause reversible thrombocytopenia, especially with prolonged use (≥10 days). This occurs due to bone marrow suppression.. Monitoring complete blood counts is recommended in patients receiving extended therapy. None of the other choices covers MRSA. Vancomycin PO does not get absorbed systemically."
                    },
                    {
                        "question": "Which of the following bacteria does metronidazole cover?",
                        "choices": [
                          "Gram-positive",
                          "Gram-negative",
                          "Anaerobes",
                          "Atypicals"
                        ],
                        "correct_answer": "Anaerobes",
                        "explanation": "Metronidazole is effective against anaerobic bacteria and certain protozoa. It is not active against typical gram-positive or gram-negative aerobes or atypical bacteria like Mycoplasma or Chlamydia."
                    },
                    {
                        "question": "A patient presents to the ED in shock due to necrotizing fasciitis. Broad-spectrum antibiotics have been started, but your colleague suggests adding clindamycin. However, the patient declines due to a history of multiple Clostridioides difficile infections. Which other antibiotic acts similarly to clindamycin for the treatment of this condition?",
                        "choices": [
                          "Doxycycline",
                          "Azithromycin",
                          "Linezolid",
                          "Gentamicin",
                          "Clarithromycin"
                        ],
                        "correct_answer": "Linezolid",
                        "explanation": "Like clindamycin, linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. In necrotizing fasciitis, protein synthesis inhibitors like clindamycin and linezolid are used to suppress bacterial toxin production, particularly in toxin-mediated infections caused by Group A Streptococcus."
                     },    
                    {
                        "question": "Which of the following antibiotics gets inactivated by lung surfactant?",
                        "choices": ["Ceftriaxone", "Azithromycin", "Daptomycin", "Vancomycin", "Rifampin"],
                        "correct_answer": "Daptomycin",
                        "explanation": "Daptomycin is inactivated by lung surfactant and therefore is ineffective for treating pneumonia."
                    },
                    {
                        "question": "Which of the following antibiotics should be used to treat methicillin-susceptible Staphylococcus aureus (MSSA)?",
                        "choices": ["Vancomycin", "Nafcillin", "Rifampin", "Azithromycin"],
                        "correct_answer": "Nafcillin",
                        "explanation": "Nafcillin and cefazolin are the preferred treatments for MSSA due to superior efficacy. Vancomycin can treat MSSA but is less effective than beta-lactams like nafcillin or cefazolin."
                    },
                    {
                        "question": "A patient is on daptomycin for MRSA endocarditis. Which laboratory test should be monitored?",
                        "choices": ["Liver function tests", "Creatine kinase", "Complete blood count", "Serum potassium"],
                        "correct_answer": "Creatine kinase",
                        "explanation": "Daptomycin can cause muscle toxicity, including rhabdomyolysis, so creatine kinase [CK] levels should be monitored weekly during therapy."
                    } 
                ]
            },
            {
                "name": "Cryptococcal infection",
                "questions": [
                    {
                        "question": "How is cryptococcal meningitis diagnosed?",
                        "choices": ["CT scan of the head", "Detection of cryptococcal antigen in CSF", "Blood culture", "CD4 count < 200/µL"],
                        "correct_answer": "Detection of cryptococcal antigen in CSF",
                        "explanation": "The diagnosis of cryptococcal meningitis is based on the detection of cryptococcal antigen in the CSF or culture of Cryptococcus neoformans from the CSF."
                    },                    
                    {
                        "question": "What is the treatment for cryptococcal meningitis?",
                        "choices": ["Amphotericin B plus flucytosine", "Vancomycin and ceftriaxone", "Fluconazole monotherapy", "Amphotericin B monotherapy"],
                        "correct_answer": "Amphotericin B plus flucytosine",
                        "explanation": "The treatment for cryptococcal meningitis involves induction with amphotericin B plus flucytosine"
                    },
                    {
                        "question": "Which drug is used as a maintenance agent for cryptococcal meningitis?",
                        "choices": ["Flucytosine", "Amphotericin B", "Fluconazole", "Vancomycin"],
                        "correct_answer": "Fluconazole",
                        "explanation": "Fluconazole is the preferred maintenance agent for cryptococcal meningitis following initial induction-treatment with amphotericin B and flucytosine."
                    },
                    {
                        "question": "How long should maintenance therapy be continued for cryptococcal meningitis in HIV-infected patients?",
                        "choices": ["6 months", "1 year", "2 years", "Until symptoms resolve"],
                        "correct_answer": "1 year",
                        "explanation": "Maintenance therapy should be continued for at least 1 year and until the patient's CD4 count is greater than 100/µL with an undetectable viral load."
                    }                    
                ]
            },
            {
                "name": "Tick-borne disease",
                "questions": [
                    {
                        "question": "What is the treatment of choice for human monocytic ehrlichiosis [HME] and human granulocytic anaplasmosis [HGA]?",
                        "choices": ["Azithromycin", "Ceftriaxone", "Doxycycline", "Amoxicillin"],
                        "correct_answer": "Doxycycline",
                        "explanation": "Doxycycline is the treatment of choice for both human monocytic ehrlichiosis [HME] and human granulocytic anaplasmosis [HGA]."
                    }
                    
                ]
            }
            
        ]
    },
    {
        "name": "Clinical Pharmacology",
        "subtopics": [
            {
                "name": "Anticoagulants",
                "questions": [
                    {
                        "question": "Which of the following anticoagulants is safe to use in patients with end-stage renal disease ?",
                        "choices": [
                          "Enoxaparin",
                          "Unfractionated heparin",
                          "Fondaparinux",
                          "Dabigatran"
                        ],
                        "correct_answer": "Unfractionated heparin",
                        "explanation": "Unfractionated heparin is the preferred anticoagulant in patients with end-stage renal disease because it does not require renal clearance. In contrast, enoxaparin (low molecular weight heparin), fondaparinux, and dabigatran are primarily excreted by the kidneys, leading to an increased risk of bleeding in ESRD patients."
                    },
                    {
                        "question": "What is the primary mechanism of action of enoxaparin?",
                        "choices": [
                          "Directly inhibits thrombin (Factor IIa)",
                          "Activates antithrombin III, primarily inhibiting Factor Xa",
                          "Inhibits vitamin K-dependent clotting factors",
                          "Directly binds to platelet receptors to prevent aggregation"
                        ],
                        "correct_answer": "Activates antithrombin III, primarily inhibiting Factor Xa",
                        "explanation": "Enoxaparin is a low molecular weight heparin (LMWH) that enhances the activity of antithrombin III, leading to the inhibition of Factor Xa with some effect on thrombin (Factor IIa)."
                    },
                    {
                        "question": "Which of the following is the antidote for dabigatran?",
                        "choices": [
                          "Protamine sulfate",
                          "Idarucizumab",
                          "Andexanet alfa",
                          "Vitamin K"
                        ],
                        "correct_answer": "Idarucizumab",
                        "explanation": "Idarucizumab is a monoclonal antibody that specifically binds to dabigatran, neutralizing its anticoagulant effect. \n\n The other choices: Protamine sulfate → unfractionated heparin\n Andexanet alfa → apixaban, rivaroxaban\nVitamin K and 4-PCC → warfarin"
                    }
                ]
            },
            {
                "name": "Antiepileptics",
                "questions": [
                    {
                        "question": "A patient presents with encephalopathy in the ED and was recently started on valproic acid. His valproic acid blood level is within the therapeutic range. What is the next best test to check?",
                        "choices": [
                          "Urinalysis",
                          "Urine drug screen",
                          "Ammonia level",
                          "Salicylate level",
                          "Acetaminophen level"
                        ],
                        "correct_answer": "Ammonia level",
                        "explanation": "Valproic acid can cause hyperammonemia by inhibiting carbamoyl phosphate synthetase I, a key enzyme in the urea cycle. This leads to impaired ammonia clearance, resulting in valproate-induced hyperammonemic encephalopathy, even when drug levels are within the therapeutic range."
                      }
                      
                    
                ]
            }
        ]
    }
]
